European Pharmaceutical Review

SEPTEMBER 5, 2023

Enhancing talent in pharmaceutical manufacturing “Talent and skills are fundamental to successful innovation and industry growth. Last month in late August 2023, another round of funding to help boost the UK medicines manufacturing sector and support innovation in the biopharma industry was announced.

Medicine 98

Medicine Manufacturing Biopharma Pharmaceutical manufacturing 98

European Pharmaceutical Review

SEPTEMBER 14, 2023

Alongside this move, AstraZeneca’s investment in major energy efficiencies in its operations, brings the total of its financial commitment to net zero, to £100 million. Once operational in early 2025, the partnership will reduce emissions by an estimated 20,000 tonnes CO 2 equivalent (CO 2 e).

Manufacturing 111

Manufacturing Medicine Pharmaceutical manufacturing Pharma 111

European Pharmaceutical Review

JULY 18, 2023

A market report by Meticulous Research has reported that rising pressure to reduce overall process costs has meant many pharma and biotech manufacturers are focusing on streamlining their processes by using quality management systems. According to the research, the pharmaceutical quality management systems market is projected to reach $3.97

Marketing 98

Marketing Management Manufacturing Pharmaceutical manufacturing 98

European Pharmaceutical Review

SEPTEMBER 26, 2022

Martin Shanahan, CEO of IDA Ireland declared: “It is a very significant day for a plant that already has a long and proud record of pharmaceutical manufacturing and innovation. Earlier this year, AbbVie was named Best Workplace for Women and ‘Biopharma Company of the Year’ at the latest Irish Pharma Industry Awards.

Manufacturing 98

Manufacturing Pharmaceutical manufacturing Biopharma Engineering 98

European Pharmaceutical Review

SEPTEMBER 22, 2022

Moreover, pharmaceutical manufacturing poses a huge detriment to the state of the planet’s ecosystem. Active pharmaceutical ingredients (APIs) are particularly impact intensive, soaking up a large quantity of resources in terms of heat, energy and water when being produced.

Transportation 105

Transportation Pharmaceutical manufacturing Biopharma Pharmaceutical 105

pharmaphorum

JANUARY 24, 2023

Drastic steps need to be taken if the UK is to reverse a steep decline in medicines manufacturing in recent years, according to a cross-industry coalition. ” Image from the Association of the British Pharmaceutical Industry (ABPI).

Manufacturing 111

Manufacturing Medicine Government Pharmaceutical manufacturing 111

pharmaphorum

DECEMBER 28, 2022

In 2018, over 60% of all new molecular entities came from smaller biopharma firms, compared with just over 30% in 2009. In the last 15 years, there has been a noticeable shift towards many prominent players effectively outsourcing innovation to start-ups due to the increasing cost of R&D.

Pharma 119

Pharma Pharmaceutical manufacturing Pharmaceutical Manufacturing 119

pharmaphorum

AUGUST 4, 2022

In particular, for the pharmaceutical industry, these talent shortages bring about a host of difficult challenges. This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. Training and development.

Recruitment 98

Recruitment Training Pharma Pharmaceutical manufacturing 98

Pharmaceutical Technology

SEPTEMBER 13, 2022

The company provides strategic assistance and regulatory support to biopharma firms across the lifecycle of the product. The PharmaLex takeover will build upon the current European presence of AmerisourceBergen in pharmaceutical supply and biopharma manufacturer services expertise.

Biopharma 52

Biopharma Manufacturing Pharmaceutical manufacturing Marketing 52

pharmaphorum

NOVEMBER 1, 2022

The new funding will establish a new pharmaceutical manufacturing scholarship programme – backed with $42.5 The university spent around $19 million on biopharma research in 2021. ” As a result, he continued, “the most advanced drugs are too costly to help as many people as they could.

Manufacturing 52

Manufacturing Biopharma Medicine Pharmaceutical manufacturing 52

European Pharmaceutical Review

DECEMBER 21, 2022

2 However, most of these efforts relating to catalysis, 3 process waste metrics, 4 lifecycle assessments, 5 pharmaceuticals in the environment 6 and the phase out of substances of concern 7 mainly mitigate the consequences of pharmaceutical manufacturing. Defossilization of pharmaceutical manufacturing.

Manufacturing 97

Manufacturing Pharmaceutical Healthcare Healthcare 97

PM360

SEPTEMBER 30, 2024

In late 2023, Deloitte found that over half of 105 surveyed global biopharma leaders were committed to reducing environmental impact and advancing sustainability by minimizing water use, sourcing sustainable materials, and overhauling supply chains.

Manufacturing 52

Manufacturing Pharma Pharmaceutical Competition 52

Clarivate

MARCH 14, 2024

Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1]

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

Clarivate

AUGUST 20, 2024

In announcing the results of price negotiations between the Centers for Medicare & Medicaid Services (CMS) and pharmaceutical manufacturers, the federal government has demonstrated that it can replicate private payers’ ability to reduce the net price of treatment while focusing on the clinical benefit of a treatment versus therapeutic alternatives (..)

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52